News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
O'Connor Donal
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| O'Connor Donal (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Exercised 7,778 shares
@ $32.86, valued at
$255.6k
Paid exercise price by delivering 3,734 shares
@ $32.86, valued at
$122.7k
Exercised 7,778 restricted stock units
@ $0 |
|
| 05/17/2023 |
4
| O'Connor Donal (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Granted 8,764 restricted stock units
@ $0 |
|
| 05/04/2023 |
4
| O'Connor Donal (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 9,132 shares
@ $0
Granted 22,044 options to buy
@ $10.95, valued at
$241.4k
|
|
| 11/23/2022 |
4
| O'Connor Donal (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Disposed/sold 10,000 shares
@ $10.5, valued at
$105k
|
|
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2022 |
4
| O'Connor Donal (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 9,852 shares
@ $0
Granted 28,000 options to buy
@ $10.15, valued at
$284.2k
|
|
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2020 |
4
| O'Connor Donal (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Exercised 6,054 shares
@ $52.76, valued at
$319.4k
Paid exercise price by delivering 2,906 shares
@ $52.76, valued at
$153.3k
Exercised 6,054 restricted stock units
@ $0 |
|
| 05/11/2020 |
4
| O'Connor Donal (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Granted 5,804 restricted stock units
@ $0 |
|
| 04/30/2020 |
4
| O'Connor Donal (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 6,635 shares
@ $0
Granted 6,000 options to buy
@ $30.14, valued at
$180.8k
|
|
| 05/20/2019 |
4
| O'Connor Donal (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Sold 1,327 shares
@ $21, valued at
$27.9k
Sold 2,673 shares
@ $20.1899, valued at
$54k
|
|
| 05/17/2019 |
4
| O'Connor Donal (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Exercised 3,971 shares
@ $49.55, valued at
$196.8k
Paid exercise price by delivering 1,907 shares
@ $49.55, valued at
$94.5k
Granted 6,054 restricted stock units
@ $0
Exercised 3,971 restricted stock units
@ $0 |
|
| 05/02/2019 |
4
| O'Connor Donal (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 8,385 shares
@ $0
Granted 6,000 options to buy
@ $23.85, valued at
$143.1k
|
|
| 06/08/2018 |
4
| O'Connor Donal (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Exercised 4,265 shares
@ $73.22, valued at
$312.3k
Paid exercise price by delivering 2,218 shares
@ $73.22, valued at
$162.4k
Exercised 4,265 restricted stock units
@ $0 |
|
| 05/17/2018 |
4
| O'Connor Donal (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Granted 3,971 restricted stock units
@ $0 |
|
| 05/03/2018 |
4
| O'Connor Donal (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 8,186 shares
@ $0
Granted 6,000 options to buy
@ $24.43, valued at
$146.6k
|
|
| 06/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/19/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 05/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/23/2016 |
4
| O'Connor Donal (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Granted 3,263 restricted stock units
@ $0 |
|
| 05/05/2016 |
4
| O'Connor Donal (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 6,000 shares
@ $0 |
|
|
|